Page last updated: 2024-10-24

chloroquine and Cerebral Nocardiosis

chloroquine has been researched along with Cerebral Nocardiosis in 2 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Antiphospholipid syndrome is an autoimmune disease that is characterised by tendency to thrombosis, obstetrical and hematological complications."1.33Nocardiosis in a patient with primary anti-phospholipid syndrome. ( Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soy, M1
Oktun, MT1
Tunçbilek, N1
Ermantaş, N1
Okten, O1
Altinay, G1
Turgut, B1
Vischer, WA1

Other Studies

2 other studies available for chloroquine and Cerebral Nocardiosis

ArticleYear
Nocardiosis in a patient with primary anti-phospholipid syndrome.
    Rheumatology international, 2006, Volume: 26, Issue:5

    Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Age

2006
Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663).
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:5

    Topics: Animals; Antitubercular Agents; Aspergillosis; Candidiasis; Chloroquine; Cricetinae; Disease Models,

1970